Prevention & lipids

The Effect of Teleprehabilitation on Adverse Events After Elective Cardiac Surgery: A Randomized Controlled Trial

J Am Coll CardiolPublished Randomised controlled trial

Authors' conclusion

Multimodal personalized teleprehabilitation resulted in a clinically relevant and statistically significant reduction of the primary endpoint in patients undergoing cardiac surgery.

Study context

Population
Patients awaiting elective cardiac surgery and procedures
Participants
394 patients
Comparison
Multimodal personalised teleprehabilitation vs control
  • Teleprehabilitationn = 197
  • Controln = 197reference
Primary endpoint
MACE:
  • CV death
  • MI
  • Stroke
  • Hospitalization for HF or other life-threatening cardiac events
  • Earlier or repeated intervention
Follow-up
From randomization until 1 year postoperatively
Methodological detailsmulticentre, blinded event adjudication
  • Multicentre
  • Blinded event adjudication

Primary result

As reported in the abstract

Difference

8.8%

95% CI 0.7%–16.8%

P = 0.032

Events by treatment group

Teleprehabilitationvs Control
difference 8.8% (95% CI 0.7%–16.8%); P = 0.032

Secondary outcomes

OutcomeAdjusted OR (95% CI)P value
Primary endpoint, patients undergoing cardiac surgery (sensitivity analysis)0.54 (0.30–0.96)P = 0.035
  • Primary endpoint, patients undergoing cardiac surgery (sensitivity analysis): effect mainly in cardiac surgery rather than transcatheter procedures

Active smokers, elevated pulmonary risk scores, elevated depression scores

Reduced with teleprehabilitation

Postoperative length of hospital stay, postoperative complications, physical fitness, obesity, malnutrition

No significant difference

Original publication

The Effect of Teleprehabilitation on Adverse Events After Elective Cardiac Surgery: A Randomized Controlled Trial. J Am Coll Cardiol. Published 11 October 2024. doi:10.1016/j.jacc.2024.10.064

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.